Dormancy in breast cancer

References

• AshworthTRA case of cancer in which cells similar to those in tumors were seen in the blood after deathAust Med J186914146149
   Google Scholar
• BraunSVoglFDNaumeBA pooled analysis of bone marrow micrometastasis in breast cancerN Engl J Med2005353879380216120859
   PubMed Web of Science ®Google Scholar
• BeckerSSolomayerEBecker-PergolaGWallwienerDFehmTPrimary systemic therapy does not eradicate disseminated tumor cells in breast cancer patientsBreast Cancer Res Treat20071062239243 Epub January 27, 200717260094
   PubMed Web of Science ®Google Scholar
• JanniWRackBSchindlbeckCThe persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrenceCancer2005103588489115666325
   PubMed Web of Science ®Google Scholar
• CristofanilliMBuddGTEllisMJCirculating tumor cells, disease progression, and survival in metastatic breast cancerN Engl J Med2004351878179115317891
   PubMed Web of Science ®Google Scholar
• RackBKSchindlbeckCAndergassenUUse of circulating tumor cells (CTC) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy to predict risk for relapse: The SUCCESS trial. ASCO Annual Meeting 2010 [abstract]J Clin Oncol201028Suppl 15s1003
   Google Scholar
• LiottaLAKleinermanJSaidelGMQuantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantationCancer Res197434599710044841969
   PubMed Web of Science ®Google Scholar
• ButlerTPGullinoPMQuantitation of cell shedding into efferent blood of mammary adenocarcinomaCancer Res19753535125161090362
   PubMed Web of Science ®Google Scholar
• MehesGWittAKubistaEAmbrosPFCirculating breast cancer cells are frequently apoptoticAm J Pathol20011591172011438448
   PubMed Web of Science ®Google Scholar
• LarsonCJMorenoJGPientaKJApoptosis of circulating tumor cells in prostate cancer patientsCytometry A2004621465315472900
   PubMedGoogle Scholar
• FidlerIJMetastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-Iodo-2′-desoxyuridineJ Natl Cancer Inst1970457737825513503
   PubMed Web of Science ®Google Scholar
• FrischSMScreatonRAAnoikis mechanismsCurr Opin Cell Biol200113555556211544023
   PubMed Web of Science ®Google Scholar
• LiottaLASaidelGMKleinermanJStochastic model of metastases formationBiometrics1976323535550963169
   PubMed Web of Science ®Google Scholar
• LiottaLASaidelMGKleinermanJThe significance of hematogenous tumor cell clumps in the metastatic processCancer Res19763638898941253177
   PubMed Web of Science ®Google Scholar
• BanysMKrawczykNBeckerSThe influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancerBreast Cancer Res Treat20121321121129 Epub May 12, 201121562707
   PubMed Web of Science ®Google Scholar
• KragDNAshikagaTMossTJBreast cancer cells in the blood: a pilot studyBreast J19995635435811348313
   PubMedGoogle Scholar
• LuzziKJMacdonaldICSchmidtEEMultistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastasesAm J Pathol199815338658739736035
   PubMed Web of Science ®Google Scholar
• CameronMDSchmidtEEKerkvlietNTemporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiencyCancer Res20006092541254610811137
   PubMed Web of Science ®Google Scholar
• KienastYVon BaumgartenLFuhrmannMReal-time imaging reveals the single steps of brain metastasis formationNat Med201016111612220023634
   PubMed Web of Science ®Google Scholar
• SleemanJPNazarenkoIThieleWDo all roads lead to Rome? Routes to metastasis developmentInt J Cancer2011128112511252621365648
   PubMed Web of Science ®Google Scholar
• PagetSDistribution of secondary growths in cancer of the breastLancet18891571
   Google Scholar
• PsailaBLydenDThe metastatic niche: adapting the foreign soilNat Rev Cancer20099428529319308068
   PubMed Web of Science ®Google Scholar
• KaplanRNRibaRDZacharoulisSVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic nicheNature2005438706982082716341007
   PubMed Web of Science ®Google Scholar
• ErlerJTWeaverVMThree-dimensional context regulation of metastasisClin Exp Metastasis2009261354918814043
   PubMed Web of Science ®Google Scholar
• KaplanRNPsailaBLydenDBone marrow cells in the ‘pre-metastatic niche’: within bone and beyondCancer Metastasis Rev200625452152917186383
   PubMed Web of Science ®Google Scholar
• DemicheliRAbbattistaAMiceliRValagussaPBonadonnaGTime distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancyBreast Cancer Res Treat19964121771858944336
   PubMed Web of Science ®Google Scholar
• PocockSJGoreSMKerrGRLong term survival analysis: the curability of breast cancerStat Med198212931047187092
   PubMedGoogle Scholar
• KarrisonTGFergusonDJMeierPDormancy of mammary carcinoma after mastectomyJ Natl Cancer Inst199991180859890174
   PubMedGoogle Scholar
• WillisRAThe Spread of Tumors in the Human BodyLondonJ&A Churchill1934
   Google Scholar
• MengSTripathyDFrenkelEPCirculating tumor cells in patients with breast cancer dormancyClin Cancer Res200410248152816215623589
   PubMed Web of Science ®Google Scholar
• HolmgrenLO’ReillyMSFolkmanJDormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppressionNat Med1995121491537585012
   PubMed Web of Science ®Google Scholar
• MorganTMLangePHPorterMPDisseminated tumor cells in prostate cancer patients after radical prostatectomy and without evidence of disease predicts biochemical recurrenceClin Cancer Res200915267768319147774
   PubMed Web of Science ®Google Scholar
• GoodisonSKawaiKHiharaJProlonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fuorescent proteinClin Cancer Res2003910 Pt 13808381414506175
   PubMed Web of Science ®Google Scholar
• WikmanHVessellaRPantelKCancer micrometastasis and tumour dormancyAPMIS20081167–875477018834417
   PubMed Web of Science ®Google Scholar
• BeckerSBecker-PergolaGWallwienerDSolomayerEFFehmTDetection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapyBreast Cancer Res Treat2006971919616319975
   PubMed Web of Science ®Google Scholar
• FrischSMFrancisHDisruption of epithelial cell-matrix interactions induces apoptosisJ Cell Biol199412446196268106557
   PubMed Web of Science ®Google Scholar
• FehmTMuellerVMarchesRTumor cell dormancy: implications for the biology and treatment of breast cancerAPMIS20081167–874275318834416
   PubMed Web of Science ®Google Scholar
• Aguirre-GhisoJAModels, mechanisms and clinical evidence for cancer dormancyNat Rev Cancer200771183484617957189
   PubMed Web of Science ®Google Scholar
• HusseinOKomarovaSVBreast cancer at bone metastatic sites: recent discoveries and treatment targetsJ Cell Commun Signal200152859921484191
   PubMedGoogle Scholar
• TownsonJLChambersAFDormancy of solitary metastatic cellsCell Cycle20065161744175016861927
   PubMed Web of Science ®Google Scholar
• WhiteDERaymentJHMullerWJAddressing the role of cell adhesion in tumor cell dormancyCell Cycle20065161756175916880738
   PubMed Web of Science ®Google Scholar
• RanganathanACAdamAPAguirre-GhisoJAOpposing roles of mitogenic and stress signaling pathways in the induction of cancer dormancyCell Cycle20065161799180716929185
   PubMed Web of Science ®Google Scholar
• Aguirre GhisoJAKovalskiKOssowskiLTumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signalingJ Cell Biol199914718910410508858
   PubMed Web of Science ®Google Scholar
• NaumovGNMacdonaldICWeinmeisterPMPersistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancyCancer Res20026272162216811929839
   PubMed Web of Science ®Google Scholar
• FisherJLThomas-MudgeRJElliottJOsteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeuticallyCancer Res20066673620362816585187
   PubMed Web of Science ®Google Scholar
• HolenICrossSSNeville-WebbeHLOsteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo – a role in tumour cell survival?Breast Cancer Res Treat200592320721516155791
   PubMed Web of Science ®Google Scholar
• Neville-WebbeHLCrossNAEatonCLOsteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosisBreast Cancer Res Treat200486326927915567943
   PubMed Web of Science ®Google Scholar
• ZhangXHWangQGeraldWLatent bone metastasis in breast cancer tied to Src-dependent survival signalsCancer Cell2009161677819573813
   PubMed Web of Science ®Google Scholar
• IndraccoloSStievanoLMinuzzoSInterruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironmentProc Natl Acad Sci U S A2006103114216422116537511
   PubMed Web of Science ®Google Scholar
• NaumovGNBenderEZurakowskiDA model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotypeJ Natl Cancer Inst200698531632516507828
   PubMedGoogle Scholar
• KleinCABlankensteinTJSchmidt-KittlerOGenetic heterogeneity of single disseminated tumour cells in minimal residual cancerLancet2002360933468368912241875
   PubMed Web of Science ®Google Scholar
• BarkanDKleinmanHSimmonsJLInhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeletonCancer Res200868156241625018676848
   PubMed Web of Science ®Google Scholar
• UhrJWPantelKControversies in clinical cancer dormancyProc Natl Acad Sci U S A201110830123961240021746894
   PubMed Web of Science ®Google Scholar
• BalicMLinHYoungLMost early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotypeClin Cancer Res200612195615562117020963
   PubMed Web of Science ®Google Scholar
• HolenIColemanREAnti-tumour activity of bisphosphonates in preclinical models of breast cancerBreast Cancer Res201012621421176176
   PubMed Web of Science ®Google Scholar
• FournierPGStresingVEbetinoFHClezardinPHow do bisphosphonates inhibit bone metastasis in vivo?Neoplasia201012757157820651986
   PubMed Web of Science ®Google Scholar
• DielIJJaschkeASolomayerEFAdjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-upAnn Oncol200819122007201118664560
   PubMed Web of Science ®Google Scholar
• ClezardinPEbetinoFHFournierPGBisphosphonates and cancer-induced bone disease: beyond their antiresorptive activityCancer Res200565124971497415958534
   PubMed Web of Science ®Google Scholar
• SolomayerEFGebauerGHirnlePInfluence of zoledronic acid on disseminated tumor cells in primary breast cancer patientsAnn Oncol Epub3 12012
   PubMedGoogle Scholar
• RobertNJDierasVGlaspyJRIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancerJ Clin Oncol201129101252126021383283
   PubMed Web of Science ®Google Scholar
• MackeyJRKerbelRSGelmonKAControlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trialsCancer Treat Rev201238667368822365657
   PubMed Web of Science ®Google Scholar
• SolomayerEFBeckerSPergola-BeckerGComparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patientsBreast Cancer Res Treat200698217918416552629
   PubMed Web of Science ®Google Scholar
• KrawczykNBanysMNeubauerHHER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumorAnticancer Res200929104019402419846945
   PubMed Web of Science ®Google Scholar
• FehmTHoffmannOAktasBDetection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cellsBreast Cancer Res2009114R5919664291
   PubMed Web of Science ®Google Scholar
• FehmTKrawczykNSolomayerEFERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patientsBreast Cancer Res2008105R7618793387
   PubMed Web of Science ®Google Scholar
• MengSTripathyDSheteSHER-2 gene amplification can be acquired as breast cancer progressesProc Natl Acad Sci U S A2004101259393939815194824
   PubMed Web of Science ®Google Scholar
• JückstockJRackBSchindlbeckCTreatment with trastuzumab in recurrence free patients with early breast cancer and persistent disseminated tumor cells (DTC) in bone marrowProceedings of the San Antonio Breast Cancer SymposiumDecember 10–14, 2008San Antonio (TX), USA
   Google Scholar
• AktasBMullerVTewesMComparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patientsGynecol Oncol20111222356360 Epub May 24, 201121605893
   PubMed Web of Science ®Google Scholar
• RackBJuckstockJGunthner-BillerMTrastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patientsArch Gynecol Obstet20122852485492 Epub June 30, 201121717141
   PubMed Web of Science ®Google Scholar
• BozionellouVMavroudisDPerrakiMTrastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancerClin Cancer Res200410248185819415623593
   PubMed Web of Science ®Google Scholar
• CuriglianoGSpitaleriGPietriEBreast cancer vaccines: a clinical reality or fairy tale?Ann Oncol200617575076216293674
   PubMed Web of Science ®Google Scholar
• SchlomJTherapeutic cancer vaccines: current status and moving forwardJ Natl Cancer Inst2012104859961322395641
   PubMed Web of Science ®Google Scholar
• SemenzaGLTargeting HIF-1 for cancer therapyNat Rev Cancer200331072173213130303
   PubMed Web of Science ®Google Scholar
• WoelfeUCloosJSauterGMolecular signature associated with bone marrow micrometastasis in human breast cancerCancer Res200363185679568414522883
   PubMed Web of Science ®Google Scholar
• WeaverVMPetersenOWWangFReversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodiesJ Cell Biol199713712312459105051
   PubMed Web of Science ®Google Scholar
• Aguirre-GhisoJAEstradaYLiuDOssowskiLERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK)Cancer Res20036371684169512670923
   PubMed Web of Science ®Google Scholar
• RanganathanACZhangLAdamAPAguirre-GhisoJAFunctional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cellsCancer Res20066631702171116452230
   PubMed Web of Science ®Google Scholar
• MatsuzawaATakedaYNaritaMOzawaHSurvival of leukemic cells in a dormant state following cyclophosphamide-induced cure of strongly immunogenic mouse leukemia (DL811)Int J Cancer19914923033091879974
   PubMed Web of Science ®Google Scholar
• RabinovskyRUhrJWVitettaESYefenofECancer dormancy: lessons from a B cell lymphoma and adenocarcinoma of the prostateAdv Cancer Res20079718920217419946
   PubMed Web of Science ®Google Scholar
• QuintanaEShackletonMSabelMSFullenDRJohnsonTMMorrisonSJEfficient tumour formation by single human melanoma cellsNature2008456722259359819052619
   PubMed Web of Science ®Google Scholar
• NashKTPhadkePANavenotJMRequirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancyJ Natl Cancer Inst200799430932117312308
   PubMedGoogle Scholar
• HorakCELeeJHMarshallJCShreeveSMSteegPSThe role of metastasis suppressor genes in metastatic dormancyAPMIS20081167–858660118834404
   PubMed Web of Science ®Google Scholar
• BarkanDGreenJEChambersAFExtracellular matrix: a gatekeeper in the transition from dormancy to metastatic growthEur J Cancer20104671181118820304630
   PubMed Web of Science ®Google Scholar
• EylesJPuauxALWangXTumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanomaJ Clin Invest201012062030203920501944
   PubMed Web of Science ®Google Scholar